BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
DRUG: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
PROCEDURE: X-Ray Imaging
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Lumbar Puncture
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Biopsy
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
BIOLOGICAL: Retifanlimab
BIOLOGICAL: Rituximab and Hyaluronidase Human
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Multigated Acquisition Scan
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Biospecimen Collection
DRUG: Polatuzumab Vedotin
DRUG: ABBV-291
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: Tegavivint
DRUG: CTO1681 10 μg
DRUG: CTO1681 20 μg
DRUG: CTO1681 30 μg
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rituximab
DRUG: ABBV-525
DRUG: AVM0703
DRUG: ABBV-319
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
DRUG: CPI-0209
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Mosunetuzumab
DRUG: DHAX
DRUG: ICE
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
DRUG: mosunetuzumab
DRUG: glofitamab
DRUG: obinutuzumab
DRUG: IMPT-314
DRUG: Belinostat
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Pharmacokinetic Study
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
DRUG: Tazemetostat
DRUG: LP-168
DRUG: LP-168
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
DRUG: E7777
GENETIC: KUR-502
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Computed Tomography
RADIATION: External Beam Radiation Therapy
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
DRUG: rituximab and lenalidomide
DRUG: rituximab and bendamustine
DRUG: rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin
DRUG: gemcitabine and oxaliplatin
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone
DRUG: Lenalidomide
DRUG: rituximab, ifosfamide, carboplatin, and etoposide phosphate
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Echocardiography
PROCEDURE: FDG-Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: DA-EPOCH
BIOLOGICAL: Rituximab
DRUG: CHOP
DRUG: Acalabrutinib
DRUG: Odronextamab
DRUG: Acalabrutinib
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Mosunetuzumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: Choline Salicylate
DRUG: Selinexor
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Decitabine and Cedazuridine
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Loncastuximab Tesirine
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Tazemetostat Pill
BIOLOGICAL: Zilovertamab vedotin
DRUG: Efineptakin alfa
DRUG: Tisagenlecleucel
DRUG: Axicabtagene ciloleucel
DRUG: Lisocabtagene Maraleucel
DRUG: ATA3219
DRUG: Acalabrutinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Lenalidomide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
BIOLOGICAL: CNTY-101
BIOLOGICAL: IL-2
DRUG: Lymphodepleting Chemotherapy
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
DRUG: Glofitamab
DRUG: Tocilizumab
DRUG: Obinutuzumab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
BIOLOGICAL: Axicabtagene Ciloleucel
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Mosunetuzumab
OTHER: Patient Observation
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: NX-2127
DRUG: Selinexor
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Zanubrutinib
DRUG: SGN-35C
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
DRUG: Methotrexate
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
PROCEDURE: Ultrasound Imaging
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
BIOLOGICAL: Lisocabtagene Maraleucel
PROCEDURE: Lymph Node Biopsy
PROCEDURE: Positron Emission Tomography
DRUG: Zanubrutinib
DIETARY_SUPPLEMENT: Ascorbic Acid
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: Gemcitabine Hydrochloride
DRUG: Ifosfamide
OTHER: Laboratory Biomarker Analysis
DRUG: Oxaliplatin
OTHER: Placebo Administration
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Decitabine
PROCEDURE: Biospecimen Collection
PROCEDURE: Core Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Central Venous Cannula Insertion
PROCEDURE: Portacath Placement
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: RNK05047
DRUG: Polatuzumab vedotin
DRUG: CD47 Antagonist ALX148
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
DRUG: Tazemetostat
DRUG: Zanubrutinib
DRUG: IKS03
PROCEDURE: Biospecimen Collection
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Oral Azacitidine
DRUG: Prednisone
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: AZD0486 IV
BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)
BIOLOGICAL: CD19 targeted CAR T Cell Therapy
BIOLOGICAL: obinutuzumab
DRUG: prednisone
DRUG: Revlimid
BIOLOGICAL: Polatuzumab
DRUG: ibrutinib
DRUG: venetoclax
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: Duvelisib
BIOLOGICAL: Tisagenlecleucel
DRUG: AC676
DRUG: IMT-009
COMBINATION_PRODUCT: Fruquintinib
DRUG: BGB-16673
DRUG: SGR-1505
DRUG: Itacitinib
BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy
DRUG: Acalabrutinib
DRUG: SGN-35T
DRUG: ABBV-101
DRUG: Venetoclax
DRUG: Ibrutinib
DRUG: Prednisone
BIOLOGICAL: Obinutuzumab
DRUG: Revlimid (lenalidomide)
DRUG: Prednisone
DRUG: Prednisolone
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Polatuzumab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: ACALABRUTINIB
DRUG: LISOCABTAGENE MARALEUCEL
DRUG: Lymphodepleting chemotherapy
BIOLOGICAL: Zilovertamab vedotin
BIOLOGICAL: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Bendamustine
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Ontorpacept
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Maplirpacept
PROCEDURE: Biopsy
DRUG: Acalabrutinib
BIOLOGICAL: Rituximab
PROCEDURE: AutoSCT OR CAR T-cell Therapy
DRUG: GDP
DRUG: Epcoritamab
DRUG: DPX-Survivac
DRUG: Pembrolizumab
DRUG: CPA
DRUG: NKTR-255 at 1.5 µg/kg
DRUG: NKTR-255 at 3.0 μg/kg
DRUG: NKTR-255 at 3.0/6.0 μg/kg
OTHER: Placebo Comparator
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Golcadomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: ONM-501
DRUG: Cemiplimab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
BIOLOGICAL: bbT369
DRUG: Rituximab Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: Relatlimab
DRUG: Nivolumab
DRUG: Nanatinostat in combination with valganciclovir
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Placebo matching for Selinexor (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Gemcitabine (combination therapy)
DRUG: Dexamethasone (combination therapy)
DRUG: Cisplatin (combination therapy)
DRUG: Selinexor (continuous therapy)
DRUG: Placebo matching for Selinexor (continuous therapy)
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: maplirpacept (PF-07901801)
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: SC262
DRUG: Venetoclax
DRUG: Tazemetostat
BIOLOGICAL: SynKIR-310
DRUG: Epcoritamab
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Oxaliplatin
DRUG: Gemcitabine
RADIATION: Bridging radiation therapy
BIOLOGICAL: Liso-cel
RADIATION: Post-infusion radiation
BIOLOGICAL: Loncastuximab Tesirine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin
PROCEDURE: Echocardiography
DRUG: Etoposide
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine
DRUG: Epcoritamab
GENETIC: cemacabtagene ansegedleucel
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Polatuzumab vedotin (PV)
DRUG: Rituximab
DRUG: Hyaluronidase
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Dexamethasone
DRUG: GCSF
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: Fludarabine (Conditional therapy)
DRUG: Cyclophosphamide Monohydrate (Conditional therapy)
DRUG: firi-cel (Experimental drug)
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Ibrutinib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride [HCl]
DRUG: Prednisone
DRUG: Polatuzumab Vedotin
DRUG: Venetoclax
DRUG: CC-99282
DRUG: Pirtobrutinib
DRUG: Belantamab Mafodotin
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: BMF-219
DRUG: Isavuconazole
DRUG: TEDDI
BIOLOGICAL: Rituximab
DRUG: Cytarabine
DRUG: TEDD
DRUG: Ibrutinib (Arms 2, 3 and 4)
DRUG: Methotrexate
DRUG: Ibrutinib (Arm 1 - Closed with Amendment G)
DRUG: Ibrutinib (Arm 4)
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Epcoritamab
DRUG: NX-1607
DRUG: Paclitaxel
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prednisolone
DRUG: NX-5948
DRUG: Pembrolizumab
DRUG: Lymphodepletion Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion
PROCEDURE: Leukapheresis
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
BIOLOGICAL: Filgrastim
DRUG: Ibrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pegfilgrastim
OTHER: Pharmacological Study
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Glofitamab
DRUG: Polatuzumab
DRUG: Rituximab
DRUG: Doxorubicin Hydrochloride
DRUG: Cyclophosphamide
DRUG: Prednisone
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Epcoritamab
PROCEDURE: Magnetic Resonance Imaging
OTHER: Patient Observation
PROCEDURE: Positron Emission Tomography
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
Get the latest thought leadership on your Diffuse Large B Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.